News & Press Releases

3/19/2014

DiscoverX to Highlight Capabilities of BioMAP® Platform for Investigative Toxicology and Safety Assessment at Society of Toxicology Meeting

Activities Include a Complimentary Workshop on Analysis of Failed Pharmaceutical Compounds Profiled in Primary Human Cell Systems Using BioMAP<sup>®</sup>

3/5/2014

Research by Structural Genomics Consortium and DiscoveRx Points to New Multi-Targeting Approaches to Cancer Therapy

Joint Publication Identifies Clinical Kinase Inhibitors that Potently Cross React with Bromodomain Epigenetic Reader Proteins

11/20/2013

Leading Drug Discovery Scientists Leverage PathHunter® Arrestin Technology for Discovery of Novel GPCR Drugs

10/22/2013

DiscoveRx Expands into Immunology Market with Launch of New Human Primary Cell-Based T Cell Autoimmune Panel

9/12/2013

DiscoveRx Announces Launch of New Human Primary Cell-Based Panels for Oncology Research

11/7/2012

Discoverx Corporation Acquires BioSeek® - Adds Primary Cell Assays to Portfolio of Drug Discovery Solutions

6/5/2012

DiscoveRx Breaks the Barriers of Conventional Cell-Based Screening With Launch of a Powerful New InCELL Hunter™ Platform

5/16/2012

DiscoveRx Introduces a High-Throughput Biochemical Screening Platform for Bromodomain Epigenetic "Reader" Proteins

5/1/2012

Comprehensive PathHunter® Assay Portfolio Driving Antibody Therapeutic Discovery Programs

2/3/2012

DiscoveRx Corporation Continues to Innovate with Solutions for Epigenetic Drug Discovery Programs

Displaying results 21-30 (of 46)

|< < 1 - 2 - 3 - 4 - 5 > >|